Abnormal Opiate Receptor Functions in Tourette's Syndrome

References

• Allolio B., Winkelmann W., Hipp F. X., Kaulen D., Mies R. Effect of a met-enkephalin analogue on ACTH, growth hormone, and prolactin in patients with ACTH hypersecretion. Journal of Clinical Endocrinology and Metabolism 1982; 55: 1–7
   PubMedGoogle Scholar
• Blankenstein J., Reyes F. I., Winter J. S. D., Faiman C. Endorphins and the regulation of the human menstrual cycle. Clinical Endocrinology 1981; 14: 287–294
   PubMedGoogle Scholar
• Bruni J. F., Van Vugt D., Marshall S., Meites J. Effects of naloxone morphine and methionine enkephalin on serum PRL, LH, FSH, TSH, and GH. Life Sciences 1977; 21: 461–466
   PubMed Web of Science ®Google Scholar
• Ching M. Morphine suppresses the proestrous surge of GnRH in pituitary portal plasma of rats. Endocrinology 1983; 112: 2209–2211
   PubMedGoogle Scholar
• De Bodo R. V. The antidiuretic action of morphine and its mechanism. Journal of Pharmacology and Experimental Therapeutics 1944; 82: 74–85
   Google Scholar
• Gillman M. A., Sandyk R. Gilles de la Tourette's syndrome: Effect of analgesic concentrations of nitrous oxide. British Medical Journal 1984; 288: 114
   PubMedGoogle Scholar
• Grossman A., Besser G. M. Opiates control ACTH through a noradrenergic mechanism. Clinical Endocrinology 1982; 17: 287–290
   PubMedGoogle Scholar
• Grossman A., Moult P. J. A., McIntyre H., Evans J., Silverstone T., Rees L. H., Besser G. M. Opiate mediation of amenorrhoea in hyperprolactinaemia and in weight loss related amenorrhea. Clinical Endocrinology 1982; 17: 379–388
   PubMed Web of Science ®Google Scholar
• Gudelsky G. A., Porter J. C. Morphine and opioid peptide induced inhibition of the release of dopamine from tuberoinfundibular neurons. Life Sciences 1979; 25: 1697–1702
   PubMed Web of Science ®Google Scholar
• Iverson L. I., Iverson S. D., Bloom F. J. Opiate receptors influence vasopressin release from nerve terminals in rat neurophypophysis. Nature 1980; 284: 350–351
   PubMedGoogle Scholar
• Koening J., Mayfield M. A., Coppings R. J., McCann S. M., Krulich L. Role of central nervous system neurotransmitters in mediating the effefts of morphine on growth hormone and prolactin secretion in the rat. Brain Research 1980; 197: 453–468
   PubMedGoogle Scholar
• Kokka N., Garcia J. F., Elliot H. W. Effects of acute and chronic administration of narcotics on growth hormone and ACTH secretion in rats. Progress in Brain Research 1973; 39: 347–360
   PubMedGoogle Scholar
• Martin W. R. Pharmacology of opioids. Pharmacological Reviews 1984; 35: 283–319
   Web of Science ®Google Scholar
• Morley J. E., Baranetzky G., Winger T. D., Carlson H. E., Hershman J. M., Melmed S., Levin S. R., Jamison K. R., Weitzman R., Chang R. J., Varner A. A. Endocrine effects of naloxone induced opiate receptor blockade. Journal of Clinical Endocrinology and Metabolism 1980; 50: 251–257
   PubMed Web of Science ®Google Scholar
• Pechnick R., George R., Poland R. E. Identification of multiple opiate receptors through neuroendocrine responses. I. Effects of agonists. The Journal of Pharmacology and Experimental Therapeutics 1985; 256: 232–238
   Google Scholar
• Penalva A., Villanueva L., Casanueva F., Cavagnini F., Gomez-Pan A. Cholinergic and histaminergic involvement in the growth hormone releasing effect of an enkephalin analog FK 33824 in man. Psychopharmacology 1983; 80: 120–124
   PubMedGoogle Scholar
• Pfeiffer A., Herz A. Endocrine actions of opioids. Hormone Metabolic Research 1984; 16: 386–397
   PubMed Web of Science ®Google Scholar
• Pfeiffer A., Herz A., Loriaux D. I., Pfeiffer D. G. Central mu and kappa opiate receptors mediate ACTH-release in rats. Endocrinology 1985; 116: 2688
   PubMedGoogle Scholar
• Pfeiffer A., Pasi A., Mehraein P., Herz A. Opiate receptor binding sites in human brain. Brain Research 1982; 248: 87–96
   PubMedGoogle Scholar
• Pfeiffer A., Pasi A., Mehraein P., Herz A. A subclassification of kappa opiate sites in human brain by use of dynorphin 1–17. Neuropeptides 1981; 2: 89–97
   Google Scholar
• Pfeiffer A., Pfeiffer D. G. Central mu and kappa-opiate receptors may mediate the opiate induced release of GH and ACTH in rats. Acta Endocrinology 1984; 264(105)40–41, (suppl.)
   Google Scholar
• Pfeiffer D. G., Pfeiffer A., Almeida O. F. X., Herz A. Opiate suppression of LH secretion involves central receptors different from those mediating opiate effects on prolactin secretion. Journal of Endocrinology 1987; 114: 469–476
   PubMedGoogle Scholar
• Rolandi E., Marabini A., Magnani G., Sannia A., Barreca T. Influence of low dose naloxone on pituitary secretion in man. European Journal of Clinical Pharmacology 1982; 22: 213–216
   PubMedGoogle Scholar
• Sandyk R. Clomiphene citrate in Tourette's syndrome. International Journal of Neuroscience, (In press)
   Google Scholar
• Sandyk R. The effects of naloxone on obsessive compulsive behavior in Tourette's syndrome. International Journal of Neuroscience 1987; 35: 93–94
   PubMed Web of Science ®Google Scholar
• Sandyk R., Bamford C. R. Gonadotropin response to naloxone challenge in Tourette's syndrome. Neurology 1987; 37: 277, (suppl. 1)
   Google Scholar
• Sandyk R., Bamford C. R., Arnold G. Independent hypothalamic-mediated modulation of FSH and ACTH by naloxone in Tourette's syndrome. Neurology 1987d; 37: 276, (suppl. 1)
   PubMed Web of Science ®Google Scholar
• Sandyk R., Bamford C. R., Binkiewicz A. Gonadotropin deficiency in Tourette's syndrome. Annals of Neurology 1987a; 22: 434
   Google Scholar
• Sandyk R., Bamford C. R., Crinnian C. Growth hormone response to naloxone challenge in Tourette's syndrome. Neurology 1987c; 37: 277, (suppl. 1)
   Google Scholar
• Sandyk R., Bamford C. R., Kwo-on-Yuen P. F. R. Prolactin responses to opioid receptor blockade and the hypothalamic dopaminergic system in Tourette's syndrome. 6th International Catecholamine Symposium, JerusalemIsrael, June 14–19, 1987b
   Google Scholar
• Sandyk R., Iacono R. P., Crinnian C., Bamford C. R., Consroe P. Effects of naltrexone in Tourette's syndrome. Annals of Neurology 1986; 20: 437
   Web of Science ®Google Scholar
• Spiegel K., Kourides I. A., Pasternak G. W. Prolactin and growth hormone release by morphine in the rat: Different receptor mechanisms. Science 1982; 217: 745–747
   PubMedGoogle Scholar
• Szligi G. R., Ludens J. H. Studies on the nature and mechanism of the diuretic action of the opioid analgesic ethylketocyclzocine. Journal of Pharmacology and Experimental Therapeutics 1982; 220: 585–591
   PubMedGoogle Scholar
• Tolis G., Hickey J., Guyda H. Effects of morphine on serum growth hormone, cortisol, prolactin, and TSH in man. Journal of Clinical Endocrinology and Metabolism 1975; 55: 1–7
   Google Scholar
• Volvaka J., Bauman J., Pevnick J., Reker D., James B., Cho D. Short-term hormonal effects of naloxone in man. Psychoneuroendocrinology 1980; 5: 225–234
   PubMedGoogle Scholar
• Weitzman R. E., Fisher D. A., Minick S., Ling N., Guillemin R. Beta-endorphin stimulates secretion of arginine vasopressin in vivo. Endocrinology 1977; 101: 1643–1646
   PubMed Web of Science ®Google Scholar